Krist Robert John 4
4 · ENDOLOGIX INC /DE/ · Filed Dec 13, 2012
Insider Transaction Report
Form 4
Krist Robert John
Chief Financial Officer
Transactions
- Sale
Common Stock
2012-12-12$14.00/sh−6,957$97,398→ 205,588 total - Sale
Common Stock
2012-12-12$13.98/sh−1,500$20,970→ 203,142 total - Sale
Common Stock
2012-12-12$13.97/sh−2,294$32,047→ 200,848 total - Award
Common Stock
2012-12-12$5.55/sh+58,370$323,954→ 219,706 total - Sale
Common Stock
2012-12-12$14.06/sh−800$11,248→ 216,706 total - Sale
Common Stock
2012-12-12$14.04/sh−100$1,404→ 215,306 total - Sale
Common Stock
2012-12-12$14.02/sh−367$5,145→ 214,939 total - Sale
Common Stock
2012-12-12$13.96/sh−1,100$15,356→ 199,748 total - Sale
Common Stock
2012-12-12$13.94/sh−9,200$128,248→ 186,098 total - Exercise/Conversion
Option to Purchase
2012-12-12−19,100→ 0 totalExercise: $5.81From: 2006-04-04Exp: 2014-04-04→ Common Stock (19,100 underlying) - Award
Common Stock
2012-12-12$5.81/sh+19,100$110,971→ 161,336 total - Sale
Common Stock
2012-12-12$14.07/sh−2,200$30,954→ 217,506 total - Sale
Common Stock
2012-12-12$14.05/sh−1,300$18,265→ 215,406 total - Sale
Common Stock
2012-12-12$14.01/sh−2,394$33,540→ 212,545 total - Sale
Common Stock
2012-12-12$13.99/sh−946$13,235→ 204,642 total - Sale
Common Stock
2012-12-12$13.93/sh−2,379$33,139→ 183,719 total - Sale
Common Stock
2012-12-12$13.91/sh−12,622$175,572→ 160,705 total - Sale
Common Stock
2012-12-12$13.90/sh−18,269$253,939→ 142,436 total - Exercise/Conversion
Option to Purchase
2012-12-12−58,370→ 37,530 totalExercise: $5.55From: 2005-08-18Exp: 2014-08-18→ Common Stock (58,370 underlying) - Sale
Common Stock
2012-12-12$13.95/sh−4,450$62,078→ 195,298 total - Sale
Common Stock
2012-12-12$13.92/sh−10,392$144,657→ 173,327 total - Sale
Common Stock
2012-12-12$14.03/sh−200$2,806→ 142,236 total